Role of MRI Breast in Detection of Ductal Carcinoma in Situ

Role of MRI Breast in Detection of Ductal Carcinoma in Situ

"This study investigates the role of Magnetic Resonance Imaging (MRI) in detecting Ductal Carcinoma in situ (DCIS) in high-risk breast cancer patients.

Improved detection rates of DCIS in high-risk patients. Enhanced diagnostic accuracy, reducing false positives and negatives. Ductal Carcinoma in situ (DCIS) is a non-invasive breast cancer where abnormal cells are confined to the milk ducts.

The Breast Imaging Reporting and Data System (BI-RADS) is a standardized scoring system used to classify breast imaging findings. Scores range from 0 (incomplete) to 6 (known biopsy-proven malignancy)."

Inclusion Criteria:

• High-risk breast cancer patients with a family history of breast cancer or genetic predispositions (e.g., BRCA mutations).
• Patients aged 30-65 years.
• Patients willing to undergo breast MRI screening for DCIS detection.

Exclusion Criteria:

• Patients with contraindications to MRI imaging (e.g., pacemakers, claustrophobia).
• Patients with a history of prior breast surgery or interventions that may interfere with imaging interpretation.